Keywords: lamictal, approval, lennox-gastaut, glaxo, wellcome, lamotrigine, been

Lamictal Approval For Lennox-Gastaut

Article | 01 September 1998

Glaxo Wellcome's Lamictal (lamotrigine) has been approved as add-ontherapy by the US Food and Drug Administration for the additional indication ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in